IMC Chicago’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $110M | Sell |
911,200
-97,800
| -10% | -$11.3M | 0.04% | 279 |
|
|
2025
Q4 | $106M | Buy |
1,009,000
+119,700
| +13% | +$11.2M | 0.04% | 280 |
|
|
2025
Q3 | $74.6M | Buy |
889,300
+11,200
| +1% | +$922K | 0.03% | 355 |
|
|
2025
Q2 | $69.5M | Sell |
878,100
-14,900
| -2% | -$1.18M | 0.03% | 312 |
|
|
2025
Q1 | $80.2M | Buy |
893,000
+132,500
| +17% | +$12.4M | 0.05% | 215 |
|
|
2024
Q4 | $75.7M | Buy |
760,500
+251,200
| +49% | +$25.9M | 0.04% | 251 |
|
|
2024
Q3 | $57.8M | Buy |
509,300
+106,600
| +26% | +$12.7M | 0.03% | 271 |
|
|
2024
Q2 | $49.9M | Buy |
402,700
+102,900
| +34% | +$13.3M | 0.03% | 298 |
|
|
2024
Q1 | $39.6M | Buy |
299,800
+77,600
| +35% | +$9.56M | 0.02% | 296 |
|
|
2023
Q4 | $24.2M | Buy |
222,200
+5,600
| +3% | +$581K | 0.02% | 408 |
|
|
2023
Q3 | $22.3M | Buy |
216,600
+14,800
| +7% | +$1.6M | 0.02% | 354 |
|
|
2023
Q2 | $23.3M | Sell |
201,800
-47,200
| -19% | -$5.36M | 0.02% | 338 |
|
|
2023
Q1 | $26.5M | Sell |
249,000
-111,500
| -31% | -$12M | 0.03% | 276 |
|
|
2022
Q4 | $40M | Buy |
360,500
+55,300
| +18% | +$5.65M | 0.06% | 188 |
|
|
2022
Q3 | $26.3M | Sell |
305,200
-134,900
| -31% | -$12M | 0.03% | 241 |
|
|
2022
Q2 | $40.1M | Buy |
440,100
+40,200
| +10% | +$3.56M | 0.06% | 167 |
|
|
2022
Q1 | $32.8M | Buy |
+399,900
| New | +$31.5M | 0.03% | 250 |
|
|
2021
Q4 | – | Sell |
-637,000
| Closed | -$24.2M | – | 1261 |
|
|
2021
Q3 | $24.2M | Buy |
637,000
+323,800
| +103% | +$24.6M | 0.03% | 320 |
|
|
2021
Q2 | $8.75M | Sell |
313,200
-124,026
| -28% | -$9.23M | 0.01% | 479 |
|
|
2021
Q1 | $32.2M | Buy |
437,226
+220,919
| +102% | +$16.3M | 0.05% | 200 |
|
|
2020
Q4 | $16.9M | Buy |
216,307
+4,297
| +2% | +$329K | 0.02% | 302 |
|
|
2020
Q3 | $16.8M | Buy |
212,010
+134,458
| +173% | +$10.5M | 0.03% | 235 |
|
|
2020
Q2 | $5.72M | Sell |
77,552
-107,315
| -58% | -$8.08M | 0.01% | 354 |
|
|
2020
Q1 | $13.6M | Buy |
184,867
+18,340
| +11% | +$1.44M | 0.03% | 174 |
|
|
2019
Q4 | $14.5M | Buy |
166,527
+36,156
| +28% | +$2.97M | 0.04% | 170 |
|
|
2019
Q3 | $10.5M | Buy |
130,371
+37,937
| +41% | +$3.04M | 0.03% | 174 |
|
|
2019
Q2 | $7.4M | Sell |
92,434
-2,515
| -3% | -$193K | 0.02% | 217 |
|
|
2019
Q1 | $7.54M | Buy |
94,949
+19,598
| +26% | +$1.47M | 0.03% | 179 |
|
|
2018
Q4 | $5.49M | Buy |
+75,351
| New | +$5.32M | 0.02% | 187 |
|
Other funds holding MRK
VCM
VPM
IMC Chicago's MRK Position: Q4 2025 in Review
IMC Chicago sold out of Merck (MRK) in Q4 2025, closing a stake of 19,187 shares — an estimated $1.8M sold.
IMC Chicago first reported a position in MRK in Q2 2019 and held it in 7 quarters. The position peaked at $4.35M in Q4 2019. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- IMC Chicago reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- IMC Chicago sold 19,187 Merck shares in Q4 2025, an estimated $1.8M.
- IMC Chicago first reported a position in Merck in Q2 2019 and held it in 7 quarters.
- IMC Chicago's Merck position peaked at $4.35M in Q4 2019.
- 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.